Represents the Company’s tenth product launch since inception in October 2023 SCHAUMBURG, Ill., June 24, 2024--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying ...
Mylan has issued a nationwide voluntary recall of injectable amiodarone, an antiarrhythmic for in-hospital use, that may have been mislabeled as tranexamic acid injection, according to the US Food and ...
Credit: FDA. The FDA has received reports of tranexamic acid injection being erroneously administered intrathecally in the perioperative setting instead of the intended intrathecal anesthetic (eg, ...
Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...
Lorient captured global attention at IMCAS 2026 with expert-led sessions, proving its excellence in safety and the ...
The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...
Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, announces the approval of an Abbreviated New Drug Application (ANDA) 1 for Tranexamic Acid Injection 1000 mg/10mL (100 mg/mL). The Food ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid Injection, USP in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results